Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Zypadhera (olanzapine) Important Safety Information from Lilly following approval by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
19/01/2009
Problem Or Issue:
Please find hereunder the safety information communication from Lilly on the association of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection) and post injection syndrome.
Zypadhera (olanzapine) - Important Safety Information
« Back
Date Printed: 05/05/2024